Works matching DE "ABIRATERONE acetate"

Results: 797
    1

    Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

    Published in:
    Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06644-7
    By:
    • Thulin, Malin Hagberg;
    • Ramberg, Håkon;
    • Nielsen, Heidi Kristin;
    • Grytli, Helene Hartvedt;
    • Sivanesan, Shivanthe;
    • Pandya, Abhilash D.;
    • Seip, Kotryna;
    • Andressen, Kjetil Wessel;
    • Linder, Anna;
    • Øijordsbakken, Miriam;
    • Poutanen, Matti;
    • Katz, Betina;
    • Halvorsen, Bente;
    • Mælandsmo, Gunhild Mari;
    • Taskén, Kristin Austlid
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 1, p. e2454253, doi. 10.1001/jamanetworkopen.2024.54253
    By:
    • Bastos, Diogo Assed;
    • Soares, Andrey;
    • Schutz, Fabio Augusto Barros;
    • Cronemberger, Eduardo;
    • de Almeida Luz, Murilo;
    • Martins, Suelen Patricia Dos Santos;
    • Muniz, David Queiroz Borges;
    • Cárcano, Flavio Mavignier;
    • Smaletz, Oren;
    • Peixoto, Fábio Affonso;
    • Gomes, Andrea Juliana;
    • Cruz, Felipe Melo;
    • Franke, Fábio André;
    • Herchenhorn, Daniel;
    • Gidekel, Rosemarie;
    • Werutsky, Gustavo;
    • Rebelatto, Taiane Francieli;
    • Gomes de Jesus, Rafaela;
    • Souza, Vinicius Carrera;
    • Fay, André Poisl
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Activity of enzamtamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel.

    Published in:
    Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 2, p. 122, doi. 10.1038/pcan.2014.53
    By:
    • Cheng, H. H.;
    • Gulati, R.;
    • Azad, A.;
    • Nadal, R.;
    • Twardowski, P.;
    • Vaishampayan, U. N.;
    • Agarwal, N.;
    • Heath, E. I.;
    • Pal, S. K.;
    • Rehman, H.-t.;
    • Leiter, A.;
    • Batten, J. A.;
    • Montgomery, R. B.;
    • Galsky, M. D.;
    • Antonarakis, E. S.;
    • Chi, K. N.;
    • Yu, E. Y.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.

    Published in:
    Life (2075-1729), 2023, v. 13, n. 5, p. 1072, doi. 10.3390/life13051072
    By:
    • Sugino, Fumiya;
    • Nakane, Keita;
    • Kawase, Makoto;
    • Ueda, Shota;
    • Tomioka, Masayuki;
    • Takeuchi, Yasumichi;
    • Tomioka-Inagawa, Risa;
    • Yamada, Toyohiro;
    • Namiki, Sanae;
    • Kumada, Naotaka;
    • Takeuchi, Shinichi;
    • Kawase, Kota;
    • Kato, Daiki;
    • Takai, Manabu;
    • Iinuma, Koji;
    • Tobisawa, Yuki;
    • Koie, Takuya
    Publication type:
    Article
    48
    49
    50